Fisher & Paykel Healthcare Corporation Limited
Simbol: FPH.AX
ASX
23.66
AUDTržna cena danes
61.8116
Razmerje P/E
3.7087
Razmerje PEG
13.82B
Kapaciteta MRK
- 0.01%
Donos DIV
Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 113.3 | 268.5 | 347.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 185.3 | 257.7 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 237.9 | 169.2 | 210.5 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 342.4 | 332.4 | 248.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 31.1 | 52.2 | 39.4 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 724.6 | 822.4 | 846 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1074.7 | 887.2 | 811.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 93.5 | 84.2 | 102.6 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 90.4 | 77.4 | 74.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1338.7 | 1129.2 | 1062 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 40.2 | 49.8 | 52.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.9 | 15.7 | 24.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 6.2 | 29.5 | 137.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 74 | 58.4 | 57.7 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 42.5 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 204.9 | 186.4 | 178.9 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 151 | 114.3 | 116.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 42.5 | 22.5 | 26.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 422.2 | 395.8 | 509.5 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 287.3 | 246.7 | 231.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1123.6 | 1094.1 | 946.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 233.2 | 219.8 | 223.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -3.1 | -4.7 | -2 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 93.5 | 269.5 | 360.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.5 | 96.6 | 108.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 23.2 | 13.3 | 19.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 234.3 | 349.1 | 482 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 4.5 | -6.3 | -54.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -250.1 | -216.3 | -214.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -64.8 | -38.4 | -58.4 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -40.5 | 48.6 | -4.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -6.5 | -81.8 | -114.1 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -17.8 | -5.3 | 60.4 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 206.4 | 123.4 | 342.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -186.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 187.2 | 74.4 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -10.6 | -82.9 | -356.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.4 | -0.1 | -45.3 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.8 | 3 | 3.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0.9 | 1 | 46.1 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -183.2 | -208.3 | -166.7 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4.3 | -14 | -10.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -184.5 | -218.4 | -172.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.4 | 0.2 | -1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 30 | -6.2 | 24.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 113.3 | 83.3 | 89.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 83.3 | 89.5 | 65 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 222.9 | 300.4 | 575 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.2 | 143.1 | 405.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1486.9 | 1521.3 | 1791.4 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 601.6 | 582.6 | 667.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 885.3 | 938.7 | 1124.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 567.4 | 506.8 | 490.4 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1168.9 | 1089.4 | 1157.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.4 | 2.4 | 1.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 318 | 431.9 | 633.8 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 307 | 467 | 660.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 72.7 | 117.9 | 178.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 250.3 | 376.9 | 524.2 |
Pogosto zastavljeno vprašanje
Kaj je Fisher & Paykel Healthcare Corporation Limited (FPH.AX) skupna sredstva?
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) skupna sredstva so 2063359237.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.601.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.051.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.153.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.219.
Kaj je Fisher & Paykel Healthcare Corporation Limited (FPH.AX) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 250300000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 136465310.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 567388691.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.